about
Computer-aided targeting of the PI3K/Akt/mTOR pathway: toxicity reduction and therapeutic opportunitiesDKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell linesMK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.Reactive oxygen species extend insect life span using components of the insulin-signaling pathway.Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer.New roles for old actors, ROS and PRMT1.The tyrosine phosphorylated pro-survival form of Fas intensifies the EGF-induced signal in colorectal cancer cells through the nuclear EGFR/STAT3-mediated pathway
P2860
Q28397537-3B14682F-9CF4-4EF3-93E4-B7E394F62DB3Q35768464-805EBEA0-32EC-4618-9A7A-53DBD99A6582Q36087979-E006F405-E81E-42CC-990E-3EC6A4319CCCQ46315436-59EE6B0D-045C-4086-AD2B-016D8C00453BQ47379071-1B52BD6A-A950-43C3-9305-F870B7D11B57Q49646675-FE239C35-53A4-4A78-986B-7F8E643BE789Q58737283-DA1B39D6-AAFF-45CE-BABE-67C3143F5087
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Regulation of AKT gene expression by cisplatin
@ast
Regulation of AKT gene expression by cisplatin
@en
type
label
Regulation of AKT gene expression by cisplatin
@ast
Regulation of AKT gene expression by cisplatin
@en
prefLabel
Regulation of AKT gene expression by cisplatin
@ast
Regulation of AKT gene expression by cisplatin
@en
P2093
P2860
P356
P1433
P1476
Regulation of AKT gene expression by cisplatin
@en
P2093
Hong-Gang Yu
Ling-Li Zhang
Xi-Ming Xu
P2860
P304
P356
10.3892/OL.2013.1132
P577
2013-01-14T00:00:00Z